Forward Industries Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________

FORM 10-Q

________________

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014.

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____.

Commission File Number: 0-6669

________________

FORWARD INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

________________

New York	13-1950672
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

477 Rosemary Ave., Suite 219, West Palm Beach, FL 33401

(Address of principal executive offices, including zip code)

(561) 465-0030

(Registrant’s telephone number, including area code)

________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [ X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

[ ] Large accelerated filer
[ ] Non-accelerated filer (Do not check if a smaller reporting company)

[ ] Accelerated filer
[X] Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

The number of shares outstanding of the registrant’s common stock, par value $0.01 per share, on May 1, 2014, which is the latest practical date prior to the filing of this report, was 8,195,808 shares.

Forward Industries, Inc.

INDEX

PART I.		FINANCIAL INFORMATION	Page No.

	Item 1.	Financial Statements
		- Consolidated Balance Sheets as of March 31, 2014 (unaudited) and September 30, 2013	4

		- Consolidated Statements of Operations and Comprehensive (Loss) Income (unaudited) for the Three and Six-Month Periods Ended March 31, 2014 and 2013	5

		- Consolidated Statements of Cash Flows (unaudited) for the Six-Month Periods Ended March 31, 2014 and 2013	6

		- Notes to Consolidated Financial Statements (unaudited)	7

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
	Item 4.	Controls and Procedures	32

PART II.		OTHER INFORMATION

	Item 1.	Legal Proceedings	34

	Item 1A.	Risk Factors	34

	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	34

	Item 3.	Defaults Upon Senior Securities	34

	Item 4.	Mine Safety Disclosures	34

	Item 5.	Other Information	34

	Item 6.	Exhibits	34

		Signatures	35

		Certifications	36

Note Regarding Use of Certain Terms

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the following terms have the meanings assigned to them as set forth below:

“we”, “our”, and the “Company” refer to Forward Industries, Inc., a New York corporation, together with its consolidated subsidiaries;
“Forward” or “Forward Industries” refers to Forward Industries, Inc.;
“common stock” refers to the common stock, $.01 par value per share, of Forward Industries, Inc.;
“Forward US” refers to Forward Industries’ wholly owned subsidiary Forward Industries (IN), Inc., an Indiana corporation;
“Forward Switzerland” refers to Forward Industries’ wholly owned subsidiary Forward Industries (Switzerland) GmbH, a Swiss corporation;

“Forward UK” refers to Forward Industries’ former wholly owned subsidiary Forward Ind. (UK) Limited, a limited company of England and Wales;

“Forward China” refers to Forward Industries Asia-Pacific Corporation (f/k/a Seaton Global Corporation), Forward’s exclusive sourcing agent in the Asia-Pacific region;

“GAAP” refers to accounting principles generally accepted in the United States;
“Commission” refers to the United States Securities and Exchange Commission;
“Exchange Act” refers to the United States Securities Exchange Act of 1934, as amended;

“Fiscal 2013” refers to our fiscal year ended September 30, 2013;

“Fiscal 2014” refers to our fiscal year ending September 30, 2014;
“Europe” refers to the countries included in the European Union;

“APAC Region” refers to the Asia Pacific Region, consisting of Australia, New Zealand, Hong Kong, Taiwan, China, South Korea, Japan, Singapore, Malaysia, Thailand, Indonesia, India, the Philippines and Vietnam;

“Americas” refers to the geographic area encompassing North, Central, and South America;

“OEM” refers to Original Equipment Manufacturer; and

“Retail” refers to the retail distribution channel.

Note Regarding Presentation of Financial Information

Certain figures included in this Quarterly Report on Form 10-Q have been subject to rounding adjustments; accordingly, figures shown as totals in certain tables may not be an arithmetic aggregation of the figures that precede them.

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Forward Industries, Inc.

CONSOLIDATED BALANCE SHEETS

	March 31,	September 30,
	2014	2013
	(Unaudited)	(Note 1)
Assets:
Current assets:
Cash and cash equivalents...........................................................................................	$6,125,422	$6,616,995
Marketable securities.....................................................................................................	1,226,127	1,080,747
Accounts receivable ......................................................................................................	4,567,664	4,382,406
Inventories.......................................................................................................................	2,112,229	2,050,710
Prepaid expenses and other current assets................................................................	438,039	390,153
Assets of discontinued operations...............................................................................	280,034	339,382
Total current assets............................................................................................	14,749,515	14,860,393

Property and equipment, net........................................................................................	111,182	129,987
Other assets.....................................................................................................................	70,071	40,493
Total Assets........................................................................................................................	$14,930,768	$15,030,873

Liabilities and shareholders’ equity
Current liabilities:
Accounts payable...........................................................................................................	$1,113,845	$3,433,408
Due to Forward China.....................................................................................................	2,046,982	107,785
Accrued expenses and other current liabilities...........................................................	829,120	1,270,457
Liabilities of discontinued operations.........................................................................	6,261	25,438
Total current liabilities.......................................................................................	3,996,208	4,837,088

Other liabilities................................................................................................................	82,811	82,811
Total Liabilities................................................................................................................	4,079,019	4,919,899

6% Senior Convertible Preferred Stock, par value $0.01 per share; 1,500,000 shares authorized; 648,846 shares issued and outstanding (aggregate liquidation value of $1,275,000)...........................................................................	774,990	716,664

Commitments and contingencies

Shareholders’ equity:
Preferred stock, par value $0.01 per share; 4,000,000 shares authorized; 2,400,000 undesignated; no undesignated shares issued and outstanding..	--	--
Series A Participating Preferred stock, par value $0.01; 100,000 authorized; no shares issued and outstanding............................................................	--	--
Common stock, par value $0.01 per share; 40,000,000 shares authorized, 8,902,218 and 8,819,095 shares issued; and 8,195,808 and 8,112,685 shares outstanding, respectively...........................................................................	89,022	88,191
Additional paid-in capital..............................................................................................	18,692,449	17,965,327
Treasury stock, 706,410 shares at cost.......................................................................	(1,260,057)	(1,260,057)
Accumulated deficit.......................................................................................................	(7,424,758)	(7,378,700)
Accumulated other comprehensive loss.....................................................................	(19,897)	(20,451)
Total shareholders’ equity.............................................................................................	10,076,759	9,394,310
Total liabilities and shareholders’ equity...................................................................	$14,930,768	$15,030,873

The accompanying notes are an integral part of the consolidated financial statements.

Forward Industries, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (UNAUDITED)

	Three Months Ended March 31,		Six Months Ended March 31,
	2014	2013	2014	2013
Net sales............................................................................	$6,699,881	$7,786,726	$15,115,358	$14,760,096
Cost of goods sold..........................................................	5,296,250	6,298,968	11,866,527	11,802,308
Gross profit......................................................................	1,403,631	1,487,758	3,248,831	2,957,788

Operating expenses:
Sales and marketing................................................	725,240	510,748	1,341,947	958,572
General and administrative....................................	811,769	770,772	1,668,260	1,844,810
Total operating expenses..............................	1,537,009	1,281,520	3,010,207	2,803,382

(Loss) income from operations...................................	(133,378)	206,238	238,624	154,406

Other expense (income):
Interest (income) expense......................................	(9,212)	1,645	(17,730)	256
(Gain) loss on marketable securities, net.............	(41,407)	(85,846)	39,433	(328,217)
Other expense (income), net..................................	199,422	3,514	152,259	14,182
Total other expense (income), net...............	148,803	(80,687)	173,962	(313,779)

(Loss) income from continuing operations before income tax expense	(282,181)	286,925	64,662	468,185
Income tax expense........................................................	438	432	463	507
(Loss) income from continuing operations	(282,619)	286,493	64,199	467,678
Loss from discontinued operations, net of tax expense of $0 and $2,055, and $0 and $2,975, respectively....	(18,395)	(138,419)	(13,786)	(180,839)
Net (loss) income............................................................	(301,014)	148,074	50,413	286,839
Preferred stock dividends and accretion............	(47,572)	--	(96,471)	--
Net (loss) income applicable to common equity	$(348,586)	$148,074	$(46,058)	$286,839

Net (loss) income............................................................	$(301,014)	$148,074	$50,413	$286,839
Other comprehensive income (loss):
Change in unrealized gains on marketable securities	--	--	--	23,744
Translation adjustments........................................	554	(14,816)	1,033	(9,201)
Total other comprehensive income (loss)	554	(14,816)	1,033	14,543
Comprehensive (loss) income.....................................	$(300,460)	$133,258	$51,446	$301,382

Net (loss) income per basic and diluted common share:
(Loss) income from continuing operations..............	$(0.04)	$0.04	$(0.01)	$0.06
Loss from discontinued operations..........................	$(0.00)	$(0.02)	$(0.00)	$(0.02)
Net (loss) income per share......................................	$(0.04)	$0.02	$(0.01)	$0.04

Weighted average number of common and common equivalent shares outstanding
Basic......................................................................	8,195,808	8,112,685	8,177,996	8,109,759
Diluted...................................................................	8,195,808	8,127,071	8,177,996	8,124,145

The accompanying notes are an integral part of the consolidated financial statements.

Forward Industries, Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	Six Months Ended March 31,
	2014	2013
Operating activities:
Net income.......................................................................................................................	$50,413	$286,839
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liability...................................................................	136,258	--
Share-based compensation.......................................................................................	128,024	226,490
Realized and unrealized loss (gain) on marketable securities..............................	39,432	(328,217)
Depreciation and amortization..................................................................................	34,011	36,094
Bad debt expense.......................................................................................................	--	103,710
Deferred rent...............................................................................................................	(16,581)	--
Changes in operating assets and liabilities:
Accounts receivable..................................................................................................	(185,257)	2,714,549
Inventories..................................................................................................................	(61,519)	1,102,098
Prepaid expenses and other current assets............................................................	11,461	44,658
Accounts payable......................................................................................................	(398,989)	(3,171,903)
Accrued expenses and other current liabilities......................................................	9,337	(1,219,221)
Net cash used in operating activities.........................................................................	(253,410)	(204,903)

Investing activities:
Purchases of marketable securities.........................................................................	(5,398,477)	(38,496,126)
Proceeds from sales of marketable securities........................................................	5,213,665	38,146,602
Purchases of property and equipment...................................................................	(15,206)	(29,510)
Net cash used in investing activities........................................................................	(200,018)	(379,034)

Financing activities:
Dividends paid on senior convertible preferred stock........................................	(38,145)	--
Net cash used in financing activities.......................................................................	(38,145)	--
Net decrease in cash and cash equivalents.............................................................	(491,573)	(583,937)
Cash and cash equivalents at beginning of period.................................................	6,616,995	4,608,246

Cash and cash equivalents at end of period...........................................................	$6,125,422	$4,024,309

Supplemental Disclosures of Cash Flow Information:
Cash paid for:
Income taxes.......................................................................................................	--	$507
Supplemental Disclosures of Non-Cash Financing Activity:
Preferred stock accretion.................................................................................	$58,326	--
Reclassification of warrant liability................................................................	$629,381	--

The accompanying notes are an integral part of the consolidated financial statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 1 OVERVIEW

Forward Industries, Inc. (“Forward” or the “Company”) was incorporated under the laws of the State of New York and began operations in 1961 as a manufacturer and distributor of specialty and promotional products. The Company designs, markets, and distributes carry and protective solutions, primarily for hand held electronic devices. The Company’s principal customer market is original equipment manufacturers, or “OEMs” (or the contract manufacturing firms of these OEM customers), that either package its products as accessories “in box” together with their branded product offerings, or sell them through their retail distribution channels. The Company’s OEM products include carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic products (such as sporting & recreational products, bar code scanners, smartphones, GPS location devices, tablets, and firearms). The Company’s OEM customers are located in the Americas, Europe, and the APAC Region. The Company does not manufacture any of its OEM products and sources substantially all of its OEM products from independent suppliers in China (refer to Note 10 – “Buying Agency and Supply Agreement”).

In the opinion of management, the accompanying consolidated financial statements presented in this Quarterly Report on Form 10-Q reflect all normal recurring adjustments necessary to present fairly the financial position and results of operations and cash flows for the interim periods presented herein, but are not necessarily indicative of the results of operations for the fiscal year ending September 30, 2014. These consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in its Annual Report on Form 10-K for the fiscal year ended September 30, 2013, and with the disclosures and risk factors presented herein and therein, respectively. The September 30, 2013 consolidated balance sheet has been derived from the audited consolidated financial statements.

NOTE 2 ACCOUNTING POLICIES

Accounting Estimates

The preparation of the Company’s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates and assumptions.

Basis of Presentation

The accompanying consolidated financial statements include the accounts of Forward and its wholly owned subsidiaries (Forward US, Forward Switzerland, and Forward UK). All significant intercompany transactions and balances have been eliminated in consolidation.

Reclassifications

Certain prior period amounts have been reclassified to conform to the current period presentation.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 2 ACCOUNTING POLICIES (CONTINUED)

6% Senior Convertible Preferred Stock

Warrants

In accordance with ASC 815-40, the Company’s warrants were previously classified as a liability, at fair value, as a result of a related registration rights agreement that contains certain requirements for registering the underlying common shares, but has no provision for penalties upon the failure to register. At each balance sheet date, this liability’s fair value was re-measured and adjusted with the corresponding change in fair value recorded in the consolidated statement of operations and comprehensive (loss) income. As the Company has met the requirements for registering the underlying common shares, the fair value of the warrants has been reclassified to additional paid-in capital in the accompanying consolidated balance sheet at March 31, 2014. The liability associated with the warrants was previously included in “Accrued expenses and other current liabilities” in the consolidated balance sheet at September 30, 2013.

NOTE 3 DISCONTINUED OPERATIONS

On June 21, 2012, the Company determined to exit its global Retail business and focus solely on growing its OEM business. The decision to eliminate the Retail division was primarily driven by the longer than estimated path to bring it to profitability and the strong net sales growth and cost rationalizations in the OEM business. The Company has substantially completed its exit of its Retail business as of March 31, 2013. The Company has not had, and does not expect to have, any continuing involvement in the Retail business after this date. Accordingly, the results of operations for the Retail division have been recorded as discontinued operations in the accompanying consolidated financial statements for the fiscal periods presented. Net loss from discontinued operations for the three-month periods ended March 31, 2014 and 2013 was approximately $18,400 and $138,400, respectively. Net loss from discontinued operations for the six-month periods ended March 31, 2014 and 2013 was approximately $13,800 and $180,800, respectively.

Assets of discontinued operations as of March 31, 2014, include approximately $280,000 relating to expected payments pursuant to a Settlement Agreement and General Release (“Settlement Agreement”) executed on July 3, 2013 between the Company and G-Form LLC (“G-Form”) in exchange for certain retail inventories, the Company’s cooperation with certain administrative matters, and a mutual general release.

NOTE 4 MARKETABLE SECURITIES

The Company classifies its marketable securities as either (i) held-to-maturity, (ii) trading, or (iii) available-for-sale. Effective October 1, 2012, the Company changed its classification of marketable equity securities and corporate bonds from available-for-sale to trading. As a result of this reclassification, a gross gain of $4,764 and a gross loss of $(28,508) was reclassed out of accumulated other comprehensive income (loss) and charged to earnings using a specific identification basis. Equity securities are carried at fair value, as determined by quoted market prices, which is a Level 1 input, as established by the fair value hierarchy under ASC 820. Corporate bonds are carried at amortized cost, which approximates market value. The corresponding unrealized holding gains or losses are recognized in earnings. The Company’s marketable securities are summarized in the table below.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 4 MARKETABLE SECURITIES (CONTINUED)

	March 31,	September 30,
	2014	2013
Trading:
Cost..................................................	$1,319,094	$954,053
Unrealized Gains............................	22,940	174,940
Unrealized Losses.........................	(115,907)	(48,246)
Total Fair Value......................	$1,226,127	$1,080,747

The net gain on marketable securities for the three-month periods ended March 31, 2014 and 2013 was approximately $41,000 and $86,000, respectively. The net (loss) gain on marketable securities for the six-month periods ended March 31, 2014 and 2013 was approximately $(39,000) and $328,000, respectively. The net (loss) gain on marketable securities is included in the accompanying consolidated statements of operations and comprehensive (loss) income.

The following table presents the Company’s fair value hierarchy for assets, consisting of marketable securities, measured at fair value on a recurring basis at March 31, 2014 and September 30, 2013:

	Level 1	Level 2	Level 3	Total

Equity securities.....................	$1,226,127	$--	$--	$1,226,127
Total assets at fair value at March 31, 2014...................	$1,226,127	$--	$--	$1,226,127

Equity securities.....................	$1,080,747	$--	$--	$1,080,747
Total assets at fair value at September 30, 2013...........	$1,080,747	$--	$--	$1,080,747

NOTE 5 SHAREHOLDERS’ EQUITY

“Blank Check” Preferred Stock

The Company is authorized to issue up to 4,000,000 shares of “blank check” preferred stock. The Board of Directors (the “Board”) has the authority and discretion, without shareholder approval, to issue preferred stock in one or more series for any consideration it deems appropriate, and to fix the relative rights and preferences thereof including their redemption, dividend and conversion rights. Of these shares, 1,500,000 shares have been authorized as the 6% Senior Convertible Preferred Stock and 100,000 shares have been authorized as the Series A Participating Preferred Stock.

6% Senior Convertible Preferred Stock with Warrants

On June 28, 2013, the Company completed the sale of (i) 381,674 shares of its newly authorized 6% Senior Convertible Preferred Stock, par value $0.01 per share (the “Convertible Preferred Stock”) and (ii) warrants to purchase a total of 381,674 shares of the Company’s common stock (“Common Stock”) (the “Warrants” and together with the Convertible Preferred Stock, the “Securities”) to accredited investors in a private placement pursuant to the terms of securities purchase agreements, dated June 28, 2013, by and between the Company and each Investor. The June 28, 2013 private placement included purchases of Securities by two directors of the Company that, in the aggregate, purchased 114,502 shares of Convertible Preferred Stock and Warrants.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 5 SHAREHOLDERS’ EQUITY (CONTINUED)

6% Senior Convertible Preferred Stock with Warrants (Continued)

On August 7, 2013, the Company completed the sale of (i) an additional 216,282 shares of its Convertible Preferred Stock and (ii) Warrants to purchase a total of 216,282 shares of the Company’s Common Stock to accredited investors in a private placement pursuant to the terms of a securities purchase agreement, dated August 7, 2013, by and between the Company and such accredited investors.

On August 14, 2013, the Company completed the sale of (i) an additional 50,890 shares of its Convertible Preferred Stock and (ii) Warrants to purchase a total of 50,890 shares of the Company’s Common Stock to accredited investors in a private placement pursuant to the terms of a securities purchase agreement, dated August 14, 2013, by and between the Company and such accredited investors.

The total aggregate purchase price paid by accredited investors via the June 28, 2013, August 7, 2013 and August 14, 2013 private placements (together, the “Investors”) for each share of Convertible Preferred Stock and Warrant was $1.965. The June 28, 2013, August 7, 2013 and August 14, 2013 private placements (together, the “Private Placements”) resulted in gross proceeds of approximately $1,275,000 to the Company. The Company has sold a total of 648,846 shares of Convertible Preferred Stock and Warrants to purchase 648,846 shares of Common Stock through these Private Placements. The Company may sell additional shares of Convertible Preferred Stock, together with related Warrants, in one or more subsequent closings.

The total purchase price paid by the Investors for each share of Convertible Preferred Stock and Warrant purchased in the Closing was $1.965, consisting of (i) fair values ranging from $1.105 to $1.145 in respect of the Convertible Preferred Stock, plus (ii) fair values ranging from $0.82 to $0.86 in respect of the Warrant. The Warrants have an initial exercise price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events. The Warrants are exercisable at any time on or after January 1, 2014 (the “Initial Exercise Date”) and terminate on the 10-year anniversary of the Initial Exercise Date. Each share of Convertible Preferred Stock is convertible into one share of Common Stock at an initial conversion price of $1.84 per share, subject to adjustment upon the occurrence of certain customary events (the “Conversion Price”). At the initial Conversion Price, the total of 648,846 shares of Convertible Preferred Stock issued in the Private Placement as of the date of the Closing are convertible into an aggregate of 692,919 shares of Common Stock. The proceeds from these Private Placements of $1,275,000 have been allocated to the Convertible Preferred Stock and the Warrants based upon their fair values assigned (net of issuance costs of approximately $69,000) of approximately $693,000 and $513,000, respectively, as of the dates of issuance.

As of March 31, 2014 and September 30, 2013, the carrying value of the Convertible Preferred Stock was approximately $775,000 and $717,000, respectively, and is included on the Company’s consolidated balance sheets as temporary equity. The change in the carrying value, or accretion, of the Convertible Preferred Stock from the issuance dates to March 31, 2014 is classified as a preferred stock dividend and is included as a component of “Net (loss) income applicable to common equity” in calculating loss per share, which was approximately $29,000 and $58,000 for the three and six- month periods ended March 31, 2014. As a result of the Convertible Preferred Stock containing a beneficial conversion feature, whereby the accounting conversion price is lower than the fair value of the common stock, the Company recorded a preferred stock dividend in the amount of approximately $508,000 for the fiscal year ended September 30, 2013. This amount has been recorded as an increase to additional paid-in capital.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Dividends on the Convertible Preferred Stock are payable, on a cumulative basis, in cash, at the rate per annum of 6% of the Liquidation Preference (as defined below) and are payable quarterly, in arrears, on each March 31, June 30, September 30 and March 31, which commenced on September 30, 2013. The Company is prohibited from paying any dividend with respect to shares of Common Stock or other junior securities in any quarter unless full dividends are paid on the Convertible Preferred Stock in such quarter. Dividends on the Convertible Preferred Stock totaled approximately $19,000 and $38,000 for the three and six-month periods ended March 31, 2014. These dividends, in addition to the accretion, totaled approximately $48,000 and $96,000 for the three and six-month periods ended March 31, 2014.

NOTE 5 SHAREHOLDERS’ EQUITY (CONTINUED)

6% Senior Convertible Preferred Stock with Warrants (Continued)

In the event of a liquidation (or deemed liquidation, as described below) of the Company, the holders of the Convertible Preferred Stock shall receive in preference to the holders of Common Stock and any junior securities of the Company an amount (the “Liquidation Preference”) equal to (i) $1.965 (the “Original Issue Price”) per each outstanding share of Convertible Preferred Stock (subject to adjustment upon the occurrence of certain customary events), plus (ii) any accrued but unpaid dividends. A Change of Control of the Company (as defined in the Certificate of Amendment) will be treated as a liquidation at the option of the holders of a majority of the Convertible Preferred Stock; provided that the amount paid to holders of Convertible Preferred Stock in such event will be equal to 101% of the Original Issue Price, plus accrued but unpaid dividends.

Each share of Convertible Preferred Stock is convertible at any time, at the option of the holder, into shares of Common Stock at the then applicable Conversion Price. In addition, upon the consent of 80% of the holders of the Convertible Preferred Stock, the Convertible Preferred Stock automatically will be converted to shares of Common Stock at the then-applicable Conversion Price.

On or after June 28, 2018, the Company may, at its option and upon at least 30 days prior written notice to the holders of the Convertible Preferred Stock, redeem all or any portion of the outstanding Convertible Preferred Stock in cash at a redemption price equal to the full Liquidation Preference as of the redemption date. In addition, at any time on or after June 28, 2023, each holder of the Convertible Preferred Stock will have the right to require the Company to redeem (provided that funds are legally available to do so) all or any portion of such holder’s outstanding Convertible Preferred Stock at a redemption price equal to the full Liquidation Preference of such shares of Convertible Preferred Stock as of the redemption date.

The Convertible Preferred Stock will vote together with the Common Stock on an as-converted basis on all matters except as required by law. In addition, for so long as 50% of the shares of Convertible Preferred Stock remains outstanding, without the approval of the holders of a majority of the Convertible Preferred Stock, voting as a separate class, the Company may not: (i) authorize or issue any equity security senior to the Convertible Preferred Stock; (ii) declare or pay any dividends on the Common Stock or any series of preferred stock that ranks junior to the Convertible Preferred Stock; (iii) increase or decrease the total number of authorized shares of Convertible Preferred Stock; (iv) alter or change the rights, preferences or privileges of the Convertible Preferred Stock so as to affect materially and adversely the Convertible Preferred Stock; or (v) increase the authorized capitalization of the Company, or otherwise amend its certificate of incorporation or bylaws in a manner which adversely affects the rights or preferences of the Convertible Preferred Stock.

During the quarter ended March 31, 2014, the Company met the requirements of the registration rights agreement for registering the underlying common shares, therefore the then fair value of the warrants of $600,000 (net of issuance costs) was reclassified to additional paid-in capital in the accompanying consolidated balance sheet at March 31, 2014. As of September 30, 2013, the liability associated with the Warrants was approximately $464,000 (net of issuance costs) and was included in “Accrued expenses and other current liabilities” in the Company’s consolidated balance sheet. The value of the warrants have been reclassed to additional paid-in capital as of March 31, 2014.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 5 SHAREHOLDERS’ EQUITY (CONTINUED)

6% Senior Convertible Preferred Stock with Warrants (Continued)

The fair value of the Warrants was determined using a Black-Scholes closed-form call option pricing model, which is considered a level 3 instrument under the fair value hierarchy. The fair values of the Warrants were estimated using the following assumptions as of March 31, 2014 (the date of the reclassification) and September 30, 2013:

	March 31, 2014	September 30, 2013
Risk-free interest rate	2.7%	2.6%
Dividend yield	--	--
Volatility	32.9%	30.0%
Expected term (in years)	9.75	10.3

The change in the fair value of the convertible preferred stock warrant liability for the six months ended March 31, 2014 is summarized below:

Balance at September 30, 2013	$493,123
Increase in fair value	136,258
Reclassification of fair value of warrants	(629,381)
Balance at March 31, 2014	$0

The following table presents the Company's fair value hierarchy for liabilities, consisting of a warrant liability, measured at fair value, prior to issuance costs, at September 30, 2013 (as noted above the fair value of the warrants liability as of March 31, 2014 was reclassified to additional paid-in capital).

	Level 1		Level 2		Level 3		Total
Warranty liability at September 30, 2013	$--		$--		$493,123		$493,123

Anti-takeover Provisions

Shareholder Rights Plan

On April 26, 2013, the Board adopted a Shareholder Rights Plan, as set forth in the Rights Agreement dated as of April 26, 2013 (the “Rights Agreement”), between the Company and American Stock Transfer & Trust Company, LLC, as Rights Agent. Pursuant to the Rights Agreement, the Board declared a dividend distribution of one Right (a “Right”) for each outstanding share of Company Common Stock, par value $0.01 per share (the “Common Stock”) to shareholders of record at the close of business on May 6, 2013, which date will be the record date, and for each share of Common Stock issued (including shares distributed from treasury) by the Company thereafter and prior to the Distribution Date (as described below and defined in the Rights Agreement). Each Right entitles the registered holder, subject to the terms of the Rights Agreement, to purchase from the Company one one-thousandth of a share of Series A Participating Preferred Stock, $0.01 par value per share (the “Series A Preferred Stock”), at an exercise price of $4.00 per one one-thousandth of a share of Series A Preferred Stock, subject to adjustment.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 5 SHAREHOLDERS’ EQUITY (CONTINUED)

Anti-takeover Provisions (Continued)

Shareholder Rights Plan (Continued)

Initially, no separate Rights Certificates will be distributed and instead the Rights will attach to all certificates representing shares of outstanding Common Stock. Subject to certain exceptions specified in the Rights Agreement, the Rights will separate from the Common Stock and become exercisable on the distribution date (the “Distribution Date”), which will occur on the earlier of (i) the 10th business day (or such later date as may be determined by the Board) after the public announcement that an Acquiring Person (as defined in the Rights Agreement) has acquired beneficial ownership of 20% or more of the Common Stock then outstanding or (ii) the 10th business day (or such later date as may be determined by the Board) after a person or group announces a tender or exchange offer that would result in a person or group of affiliated and associated persons beneficially owning 20% or more of the Common Stock then outstanding.

“Blank Check” Preferred Stock

As discussed above, the Company is authorized to issue up to 4,000,000 shares of “blank check” preferred stock. The Board has the authority and discretion, without shareholder approval, to issue preferred stock in one or more series for any consideration it deems appropriate, and to fix the relative rights and preferences thereof including their redemption, dividend and conversion rights. Of these shares, 1,500,000 shares have been authorized as the 6% Senior Convertible Preferred Stock and 100,000 shares have been authorized as the Series A Participating Preferred Stock.

Stock Repurchase

In September 2002 and January 2004, the Board authorized the repurchase of up to an aggregate of 486,200 shares of outstanding common stock. Under those authorizations, as of March 31, 2014, the Company had repurchased an aggregate of 172,603 shares at a cost of approximately $403,000, but none during the three and six-month periods ended March 31, 2014 and 2013.

Changes in Shareholders’ Equity

Changes in shareholders’ equity for the six-month period ended March 31, 2014 are summarized below:

		Common Stock				Treasury Stock
	Total	Number of Shares	Par Value	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Number of Shares	Amount	Accumulated Other Comprehensive Income (Loss)
Balance at September 30, 2013	$9,394,310	8,819,095	$88,191	$17,965,327	$(7,378,700)	706,410	$(1,260,057)	$(20,451)
Share-based compensation	128,024	83,123	831	127,193	--	--	--	--
Preferred stock accretion and dividends	(96,471)	--	--	--	(96,471)	--	--	--
Foreign currency translation	554	--	--	--	--	--	--	554
Reclassification of Warrant liability	599,929	--	--	599,929	--	--	--	--
Net income	50,413	--	--	--	50,413	--	--	--
Balance at March 31, 2014	$10,076,759	8,902,218	$89,022	$18,692,449	$(7,424,758)	706,410	$(1,260,057)	$(19,897)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 6 SHARE-BASED COMPENSATION

2011 Long Term Incentive Plan

In March 2011, shareholders of the Company approved the 2011 Long Term Incentive Plan (the “2011 Plan”), which authorizes 850,000 shares of common stock for grants of various types of equity awards to officers, directors, employees, consultants, and independent contractors. Under the 2011 Plan, as of March 31, 2014, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) has approved grants of restricted common stock and stock options to purchase an aggregate of 1,327,500 shares of common stock to certain of the Company’s executive officers and employees (1,032,500 shares), a consultant (160,000 shares), non-employee directors (130,000 shares), and to a non-employee executive officer (5,000 shares). Of these awards, as of March 31, 2014, 585,647 shares were forfeited and reverted to, and are eligible for re-grant under, the 2011 Plan. The total shares of common stock available for grants of equity awards under the 2011 Plan was 108,147 as of March 31, 2014. The prices at which equity awards may be granted and the exercise prices of stock options granted may not be less than the fair market value of the common stock as quoted at the close on the Nasdaq Stock Market on the grant date. The Compensation Committee administers the 2011 Plan. Options generally expire ten years after the date of grant and vest one year from the date of grant for non-employee directors, and, in the case of initial grants to officers and employees, vest over five years with 50%, 25% and 25% vesting on the third, fourth, and fifth anniversary of the grant date, respectively. Options granted under a consulting agreement in November 2011 expire three years after the grant date and vested equally over the term of the consulting agreement, which concluded February 29, 2012.

2007 Equity Incentive Plan

The 2007 Equity Incentive Plan (the “2007 Plan”), which was approved by shareholders of the Company in May 2007, and, as amended in February 2010, authorizes an aggregate of 800,000 shares of common stock for grants of restricted common stock and stock options to officers, employees, and non-employee directors of the Company. Under the 2007 Plan, the Compensation Committee approved awards of restricted common stock and stock options of 1,092,375, in the aggregate, to certain officers, employees and non-employee directors. Of these awards, as of March 31, 2014, 307,390 shares were forfeited and reverted to, and are eligible for re-grant under, the 2007 Plan. The total shares of common stock available for grants of equity awards under the 2007 Plan was 15,015 as of March 31, 2014. The prices at which restricted common stock may be granted and the exercise price of stock options granted may not be less than the fair market value of the common stock as quoted at the close on the Nasdaq Stock Market on the grant date. The Compensation Committee administers the 2007 Plan. Options generally expire ten years after the date of grant, and in the case of non-employee directors, vest on the first anniversary of the date of grant. In the case of officers and employees, options either vest in equal amounts over three to five years or vest over five years with 50%, 25% and 25% vesting on the third, fourth, and fifth anniversary of the grant date, respectively. Restricted stock grants generally vest in equal proportions over three years.

1996 Stock Incentive Plan

The Company’s 1996 Stock Incentive Plan (the “1996 Plan”) expired in accordance with its terms in November 2006. The exercise price of incentive options granted under the 1996 Plan to officers, employees, and non-employee directors of the Company was required by 1996 Plan provisions to be equal at least to the fair market value of the common stock at the date of grant. In general, options under this plan expire ten years after the date of grant and generally vest in equal proportions over three years. Unexercised options granted prior to 1996 Plan expiration remain outstanding until the earlier of exercise or option expiration. Under the 1996 Plan, 30,000 fully vested common stock options are the only awards that remain outstanding and unexercised, all at exercise prices higher than the fair market value of the common stock at March 31, 2014.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 6 SHARE-BASED COMPENSATION (CONTINUED)

Stock Option Awards

Under the 2011 and 2007 Plans, the Compensation Committee has approved awards of stock options to purchase an aggregate of 1,770,000 shares of common stock to the Company’s current and certain former non-employee directors, to certain key employees, to current and certain former Company officers, and to a consultant, of which awards covering 255,000 shares from the 2007 Plan and 559,000 shares from the 2011 Plan of common stock were forfeited, with such shares reverting to the respective plans and eligible for grant. The exercise prices of the awards granted was, in each case equal, to the closing market value of the Company’s common stock on the Nasdaq Stock Market on the various grant dates.

The Company recognized compensation expense of approximately $35,000 and $92,000 in continuing operations for stock option awards in its consolidated statements of operations and comprehensive (loss) income for the three-month periods ended March 31, 2014 and 2013, respectively, and $66,000 and $128,000 for the six-month periods ended March 31, 2014 and 2013, respectively.

As of March 31, 2014, there was approximately $88,000 of total unrecognized compensation cost related to 266,084 shares of unvested stock option awards granted under the 2007 and 2011 Plans, which is expected to be recognized over the remainder of the weighted average vesting period (extending to August 2016).

	Shares	Weighted Average Exercise Price	Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding at September 30, 2013	897,000	$2.98	6.1	$ --
Granted..............................................	32,500	1.59	9.7
Exercised...........................................	--	--
Forfeited...........................................	(28,500)	3.61
Expired..............................................	--	--
Outstanding at March 31, 2014	901,000	$2.91	5.7	$59,025

Options expected to vest at March 31, 2014..............................	237,251	$3.66	8.1	$12,025

Options vested and exercisable at March 31, 2014..............................	634,916	$2.97	4.7	$47,000

During the three and six-month period ended March 31, 2014, the Company granted 32,500 stock options at a weighted average grant date fair value of $0.90. During the three and six-month period ended March 31, 2013, the Company granted 280,000 stock options at a weighted average grant date fair value of $0.91.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 6 SHARE-BASED COMPENSATION (CONTINUED)

Stock Option Awards (Continued)

The fair value of each stock option on the date of grant was estimated using the Black-Scholes option-pricing formula applying the following assumptions for each respective period:

	For the Three and Six-Month Periods Ended March 31,
	2014	2013
Expected term (in years)....	5.0	5.0
Risk-free interest rate..........	1.5%	0.6% – 0.7%
Expected volatility..............	67.6%	70.0% - 70.4%
Expected dividend yield.....	0%	0%
Forfeiture rate......................	10%	5%

The expected term represents the period over which the stock option awards are expected to be outstanding. The Company based the risk-free interest rate used in its assumptions on the implied yield currently available on U.S. Treasury zero-coupon issues with a remaining term equivalent to the award’s expected term. The volatility factor used in the Company’s assumptions is based on the historical price of its stock over the most recent period commensurate with the expected term of the award. The Company historically has not paid any dividends on its common stock and had no intention to do so on the date the share-based awards were granted. Accordingly, the Company used a dividend yield of zero in its assumptions. The Company estimates the expected term, volatility and forfeitures of share-based awards based upon historical data.

Restricted Stock Awards

Under the 2011 Plan and 2007 Plan, the Compensation Committee has approved and granted awards of 649,875 shares of restricted stock, in the aggregate, to certain key employees and current non-employee directors. Of these awards, 283,928 shares have vested, 40,671 shares have been forfeited, and 38,366 shares have expired. Such forfeited and expired shares have reverted to, and are eligible for re-grant under, the 2007 Plan. Vesting of restricted stock awards is generally subject to a continued service condition with one-third of the awards vesting each year on the three successive anniversary dates of the grant date, typically commencing on the first such anniversary date. The fair value of the awards granted was equal to the closing market value of the Company’s common stock as quoted on the Nasdaq Stock Market on the grant date. During the three-month periods ended March 31, 2014 and 2013, the Company recognized approximately $63,000 and $59,000, respectively, of compensation in continuing operations in its consolidated statements of operations and comprehensive (loss) income related to restricted stock awards. During the six-month periods ended March 31, 2014 and 2013, the Company recognized approximately $62,000 and $98,000, respectively, of compensation in continuing operations in its consolidated statements of operations and comprehensive (loss) income related to restricted stock awards.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 6 SHARE-BASED COMPENSATION (CONTINUED)

The following table summarizes restricted stock activity under the 2011 Plan and 2007 Plan from September 30, 2013 through March 31, 2014:

	Shares	Weighted Average Grant Date Fair Value
Non-vested balance at September 30, 2013...........	371,375	$1.16
Changes during the period:
Shares granted.....................................................	95,000	1.59
Shares vested......................................................	(83,123)	1.16
Shares forfeited...................................................	(40,671)	1.16
Shares expired.....................................................	(15,000)	1.16
Non-vested balance at March 31, 2014..................	327,581	$1.29

As of March 31, 2014, there was approximately $200,000 of total unrecognized compensation cost related to shares of unvested restricted stock awards (reflected in the table above) granted under the 2011 Plan and 2007 Plan. That cost is expected to be recognized over the remainder of the requisite service (vesting) periods (through November 2016). The total grant date fair value of restricted stock that vested during the six-month period ended March 31, 2014 was approximately $96,000.

Warrants

As of March 31, 2014, warrants to purchase 75,000 shares of the Company’s common stock at an exercise price of $1.75 issued in fiscal year ended 1999 were outstanding. By their terms these warrants expire 90 days after a registration statement registering common stock (other than pursuant to employee benefit plans) is declared effective by the Commission. As of March 31, 2014, no such registration statement has been filed with the Commission.

NOTE 7 INCOME TAXES

As of March 31, 2014, and September 30, 2013, the Company has no unrecognized income tax benefits. At March 31, 2014, the Company had available total net operating loss carryforwards for U.S. Federal and state income tax purposes of approximately $7,566,000 and $3,553,000, respectively, expiring through 2034, resulting in deferred tax assets in respect of U.S. Federal and state income taxes of approximately $2,437,000 and $324,000, respectively. In addition, at March 31, 2014, the Company had total available net operating loss carryforwards for foreign income tax purposes of approximately $4,782,000 resulting in a deferred tax asset of approximately $421,000, expiring through 2020. Total net deferred tax assets, before valuation allowances, was $3,840,000 at March 31, 2014 and $3,841,000 at September 30, 2013, respectively. Undistributed earnings of the Company’s foreign subsidiaries are considered to be permanently invested; therefore, in accordance with U.S. generally accepted accounting principles, no provision for U.S. Federal and state income taxes would result. As of March 31, 2014, there were no accumulated earnings of any of the Company’s foreign subsidiaries.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 7 INCOME TAXES (CONTINUED)

As of March 31, 2014, as part of its periodic evaluation of the necessity to maintain a valuation allowance against its deferred tax assets, and after consideration of all factors, both positive and negative (including, among others, projections of future taxable income, current year net operating loss carryforward utilization and the extent of the Company’s cumulative losses in recent years), the Company determined that, on a more likely than not basis, it would not be able to use its remaining deferred tax assets (except in respect of United States income taxes in the event the Company elects to effect the repatriation of certain foreign source income of its Swiss subsidiary, which income is currently considered to be permanently invested and for which no United States tax liability has been accrued). Accordingly, the Company has determined to maintain a full valuation allowance against its total deferred tax assets. As of March 31, 2014 and September 30, 2013, the valuation allowances were approximately $3,840,000 and $3,841,000, respectively. If the Company determines in a future reporting period that it will be able to use some or all of its deferred tax assets, the adjustment to reduce or eliminate the valuation allowance would reduce its tax expense and increase after-tax income. Changes in deferred tax assets and valuation allowance are reflected in the “Income tax expense (benefit)” line item of the Company’s consolidated statements of operations and comprehensive (loss) income. Based on the expected level of taxable income for the fiscal year ending September 30, 2014 and the availability of the aforementioned net operating loss carryforward, the Company’s effective tax rate is immaterial.

All fiscal years prior to the fiscal year ended September 30, 2010 are closed to Federal and State examination, except with respect to net operating losses generated in prior fiscal years.

NOTE 8 (LOSS) INCOME PER SHARE

Basic per share data for each period presented is computed using the weighted-average number of shares of common stock outstanding during each such period. Diluted per share data is computed using the weighted-average number of common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares that would be issued upon the exercise of stock options and conversion of 6% Senior Convertible Preferred Stock and warrants computed using the if-converted method. Diluted (loss) income per share data for the three-month periods ended March 31, 2014 and 2013, exclude 1,624,846 and 1,286,741 of outstanding common-equivalent shares as inclusion of such shares would be anti-dilutive. Diluted income per share data for the six-month periods ended March 31, 2014 and 2013, exclude 1,532,346 and 1,286,741 of outstanding common-equivalent shares as inclusion of such shares would be anti-dilutive.

NOTE 9 COMMITMENTS AND CONTINGENCIES

Employment and Agreements

Robert Garrett, Jr. Employment Agreement

Under his employment agreement, which was effective as of March 1, 2012, Mr. Robert Garrett, Jr. is currently employed as the Company’s Chief Executive Officer and his annual salary is $250,000 (and effective March 1, 2014, $300,000 per annum). In executing his employment agreement, Mr. Garrett received a signing bonus of $9,167. During the fiscal year ended September 30, 2012 (Mr. Garrett’s first year of employment), he received a bonus of $50,000. In addition, during each year of his employment, Mr. Garrett is eligible to receive an annual bonus at the discretion of the Compensation Committee in a combination of cash or equity-based compensation. Mr. Garrett received a total bonus of $100,000 for the fiscal year ended September 30, 2013. Mr. Garrett’s employment agreement also entitles him to awards of stock options to purchase an aggregate of 200,000 shares of the Company’s common stock pursuant to the 2011 Plan, which have been granted in their entirety.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 9 COMMITMENTS AND CONTINGENCIES (CONTINUED)

Employment and Agreements (Continued)

Robert Garrett, Jr. Employment Agreement (Continued)

Mr. Garrett’s employment agreement provides for successive one-year renewal terms, unless either party provides written notice of its intention not to renew the agreement not later than 90 days prior to the end of the term (or renewal period). In the event of the termination of Mr. Garrett’s employment, depending on the circumstances, Mr. Garrett could be entitled to receive a severance payment which could be up to (12) twelve months of his salary, and under certain circumstances, the immediate vesting of any unvested options pursuant to applicable equity compensation plans, as well as any accrued discretionary bonus.

Mr. Garrett’s employment agreement binds him to customary non-competition and non-solicitation covenants of up to one year following the expiration of the employment term.

James O. McKenna III Employment Agreement

James O. McKenna III serves as the Company’s Chief Financial Officer, Treasurer and Assistant Secretary pursuant to an Amended Employment Agreement, dated as of April 1, 2011 (the “Employment Agreement”), between the Company and Mr. McKenna. On November 8, 2012, Mr. McKenna’s Employment Agreement was further amended (the “Amendment”) in connection with the logistical coordination, planning and implementation of the move of the Company’s executive offices to West Palm Beach, Florida from Santa Monica, California, and his relocation from California to Florida at the Company’s request. Among other things, the Amendment reduced his base salary to $210,000 per annum from $225,000 per annum, eliminated his housing allowance of $90,000 per annum (paid pursuant to the Employment Agreement), and provided for a bonus payment in the amount of $172,456, less applicable withholdings and deductions, all subject to the provisions provided in the Amendment. Approximately $86,000 of such bonus payment was attributed as a bonus to Mr. McKenna in the fiscal year ended September 30, 2012, and half of the remainder was attributed to Mr. McKenna’s bonus in the fiscal year ended September 30, 2013. Mr. McKenna received a total bonus of $86,000 for the fiscal year ended September 30, 2013. Of this bonus, half represented a cash payout and the other half reduced a portion of the remainder of Mr. McKenna’s bonus prepayment from the fiscal year ended September 30, 2012 as previously described. The Company expensed the remainder as an estimated bonus for Mr. McKenna in continuing operations for the fiscal year ended September 30, 2013. The Employment Agreement automatically renewed on December 31, 2013 for one year with an automatic renewal for successive terms of one year each. Pursuant to the Employment Agreement, Mr. McKenna is entitled to a payment equal to one year of his salary as severance in the event of his termination “without cause” and termination for “good reason” (as such terms are defined in the Employment Agreement).

Guarantee Obligation

In February 2010, Forward Switzerland and its European logistics provider (freight forwarding and customs agent) entered into a Representation Agreement (the “Representation Agreement”) whereby, among other things, the European logistics provider agreed to act as Forward Switzerland’s Fiscal representative in The Netherlands for the purpose of providing services in connection with any value added tax matters. As part of this agreement, which succeeds a substantially similar agreement (except as to the amount and term of the undertaking) between the parties that expired June 30, 2009, Forward Switzerland agreed to provide an undertaking (in the form of a bank letter of guarantee) to the logistics provider with respect to any value added tax liability arising in The Netherlands that the logistics provider is required to pay to Dutch tax authorities on its behalf.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 9 COMMITMENTS AND CONTINGENCIES (CONTINUED)

Guarantee Obligation (Continued)

As of February 1, 2010, Forward Switzerland entered into a guarantee agreement with a Swiss bank relating to the repayment of any amount up to €75,000 (equal to approximately $104,000 as of March 31, 2014) paid by such bank to the logistics provider in order to satisfy such undertaking pursuant to the bank letter of guarantee. Forward Switzerland would be required to perform under the guarantee agreement only in the event that: (i) a value added tax liability is imposed on the Company’s sales in The Netherlands, (ii) the logistics provider asserts that it has been called upon in its capacity as surety by the Dutch Receiver of Taxes to pay such taxes, (iii) Forward Switzerland or the Company on its behalf fails or refuses to remit the amount of value added tax due to the logistics provider upon its demand, and (iv) the logistics provider makes a drawing under the bank letter of guarantee. Under the Representation Agreement, Forward Switzerland agreed that the letter of guarantee would remain available for drawing for three years following the date that its relationship terminates with the logistics provider to satisfy any value added tax liability arising prior to expiration of the Representation Agreement but asserted by The Netherlands after expiration.

The initial term of the bank letter of guarantee expired February 28, 2011, but renews automatically for one-year periods until February 28, 2015, unless Forward Switzerland provides the Swiss bank with written notice of termination at least 60 days prior to the renewal date. It is the intent of Forward Switzerland and the logistics provider that the bank letter of guarantee amount be adjusted annually. In consideration of the issuance of the letter of guarantee, Forward Switzerland has granted the Swiss bank a security interest in all of its assets on deposit with, held by, or credited to Forward Switzerland’s accounts with, the Swiss bank (approximately $1,491,000 at March 31, 2014). As of March 31, 2014, the Company had not incurred a liability in connection with this guarantee.

NOTE 10 RELATED PARTY TRANSACTIONS

Buying Agency and Supply Agreement

On March 12, 2012, the Company entered into a Buying Agency and Supply Agreement (the “ Sourcing Agreement”) with Forward Industries Asia Pacific Corporation (f/k/a Seaton Global Corporation), a British Virgin Islands corporation (“Forward China”), dated as of March 7, 2012. On March 13, 2014, the Company entered into Amendment No. 1 to the Sourcing Agreement with Forward China, dated as of March 11, 2014. The Sourcing Agreement, as amended, provides that upon the terms and subject to the conditions set forth therein, Forward China will act as the Company’s exclusive buying agent and supplier of Products (as defined in the Sourcing Agreement) in the Asia Pacific region. The Company will purchase products at Forward China’s cost and pay Forward China a monthly fee for services it provides under the Sourcing Agreement. The Sourcing Agreement, as amended, terminates on March 11, 2015, subject to renewal. Terence Wise, a director of the Company, is a principal of Forward China. In addition, Jenny P. Yu, a Managing Director of Forward China, owns shares of the Company’s common stock. The Company recognized approximately $249,000 and $241,000, respectively, during the three-month periods ended March 31, 2014 and 2013 and $544,000 and $492,000, respectively, during the six-month periods ended March 31, 2014 and 2013 of Forward China service fees, which are included as a component of costs of goods sold in continuing operations in the accompanying consolidated statements of operations and comprehensive (loss) income. At March 31, 2014 and September 30, 2013, there were approximately $2,047,000 and $108,000, respectively, of service fees payable to Forward China.

Investment Management Agreement

On April 16, 2013, the Company entered into an Investment Management Agreement (the “Investment Agreement”) with LaGrange Capital Administration, L.L.C. (“LCA”), pursuant to which the Company retained LCA to manage certain investment accounts funded by the Company (collectively, the “Account”). Frank LaGrange Johnson, the Company’s Chairman of the Board, serves as the Managing Member of LCA.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 10 RELATED PARTY TRANSACTIONS (CONTINUED)

Investment Management Agreement (Continued)

Pursuant to the Investment Agreement, LCA is authorized, subject to supervision of the Investment Committee of the Board and the terms and conditions of the Investment Agreement, to take all actions and make all decisions regarding the investment and reinvestment of the assets of the Account utilizing the Investment Strategy (as defined in the Investment Agreement). As compensation for its services to the Company, LCA shall be entitled to advisory fees, comprised of an asset-based fee and a performance fee, as provided in the Investment Agreement. The asset-based fee will equal 1% per annum of the average Account Net Asset Value (“Account NAV”). The performance fee will equal 20% of the increase (if any) in the Account NAV over an annual period. No performance fee will be payable for any annual period in which the Account NAV at the end of such annual period is below the highest Account NAV at the end of any previous annual period. In addition to such advisory fees, the Company will reimburse LCA for certain investment and operational expenses. Under the Investment Agreement, the Company or its designees may make cash withdrawals from the Account on March 31, June 30, September 30 or December 31 of each year upon 45 days’ prior written notice to LCA; provided, that, in the event of a breach of certain terms of the Investment Agreement, the Company may make a complete cash withdrawal from the Account immediately without LCA’s consent. During the three and six-month periods ended March 31, 2014, the Company recognized approximately $3,000 and $6,000, respectively, of expense in continuing operations in its consolidated statements of operations and comprehensive (loss) income related to asset based advisory fees. There were no asset based advisory fees recorded during the three and six-month periods ended March 31, 2013. The Company has not recorded any expense related to performance based advisory fees during the three and six-month periods ended March 31, 2014.

The Investment Agreement is effective as of February 1, 2013 and shall continue until the second anniversary of the effective date. Thereafter, the term of the Investment Agreement shall automatically renew for additional one year terms unless terminated in accordance with the terms of the Investment Agreement or if a party provides notice to the other party no less than 60 days prior to the end of a term of its decision to terminate the Investment Agreement at the end of the then current term.

The Company did not invest any additional funds with LCA during the three and six-month periods ended March 31, 2014 and 2013.

During the three-month periods ended March 31, 2014 and 2013, the Company purchased approximately $1,296,000 and $32,427,000 of marketable securities, respectively. During the six-month periods ended March 31, 2014 and 2013, the Company purchased approximately $5,398,000 and $38,496,000 of marketable securities, respectively. During the three-month periods ended March 31, 2014 and 2013, the Company sold approximately $1,282,000 and $32,690,000 of marketable securities, respectively. During the six-month periods ended March 31, 2014 and 2013, the Company sold approximately $5,214,000 and $38,147,000 of marketable securities, respectively. As a result of these activities, the Company recognized net investment gains (losses) of approximately $41,000 and $86,000 during the three-month periods ended March 31, 2014 and 2013, respectively, and $(39,000) and $328,000 during the six month periods ended March 31, 2014 and 2013, respectively.

New York Office Rent

In February 1, 2014, the Company began leasing office space in New York, New York for its Chief Executive Officer at a rate of $2,500 per month from LCA. This lease is month-to-month and is cancellable by either the Company or LCA at any time. Effective April 1, 2014, LCA increased the monthly rental charge (inclusive of rent, allocable share of office assistant, and equipment leases) from $2,500 to approximately $12,700 per month. During the three and six-month periods ended March 31, 2014, the Company recognized approximately $5,000 of rent expense in continuing operations in its consolidated statements of operations and comprehensive (loss) income related to the New York office.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 11 LEGAL PROCEEDINGS

From time to time, the Company may become a party to other legal actions or proceedings in the ordinary course of its business. As of March 31, 2014, there were no such actions or proceedings, either individually or in the aggregate, that, if decided adversely to the Company’s interests, the Company believes would be material to its business.

NOTE 12 OPERATING SEGMENT INFORMATION

As of March 31, 2014, the Company reported and managed its continuing operations based on a single operating segment: the design and distribution of carry and protective solutions, primarily for hand held electronic devices. Products designed and distributed by this segment include carrying cases and other accessories for medical monitoring and diagnostic kits, portable consumer electronic devices (such as smartphones, tablets, personnel computers, notebooks, and GPS devices), and a variety of other portable electronic and non-electronic products (such as firearms, sporting, and other recreational products). This segment operates in geographic regions that include primarily the APAC Region, the Americas, and Europe. Geographic regions are defined by reference primarily to the location of the customer or its contract manufacturer.

On June 21, 2012, the Company determined to wind down its Retail segment, which commenced during the three-month period ended March 31, 2011, and focus solely on growing its OEM business. The decision to eliminate the Retail division was primarily driven by the longer than estimated path to bring it to profitability and the strong net sales growth and cost rationalizations in the OEM business. The Company has substantially completed its exit of its Retail business as of March 31, 2014. The Company has not had, and does not expect to have, any continuing involvement in the Retail business after this date.

Revenues from External Customers

The following table presents net sales by geographic region.

	(dollars in millions)
	For the Three-Month Periods Ended March 31,		For the Six-Month Periods Ended March 31,
	2014	2013	2014	2013
Americas:
United States.........................	$1.7	$2.5	$4.1	$5.4
Other.......................................	0.2	0.4	0.2	0.4
Total Americas...............	$1.9	$2.9	$4.3	$5.8

APAC:
Hong Kong............................	$2.1	$1.4	$4.4	$2.6
Other.......................................	0.6	0.8	1.6	$1.7
Total APAC Region.......	$2.7	$2.2	$6.0	$4.3

Europe:
Germany.................................	$1.2	$1.6	$2.5	$3.6
Poland....................................	0.8	1.1	1.9	$1.1
Other......................................	0.2	--	0.4	--
Total Europe...................	$2.2	$2.7	$4.8	$4.7
Total net sales............................	$6.7	$7.8	$15.1	$14.8

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE 12 OPERATING SEGMENT INFORMATION (CONTINUED)

Long-Lived Assets (Net of Accumulated Depreciation and Amortization)

Identifiable long-lived assets, consisting predominately of property and equipment, by geographic region are as follows:

	(dollars in thousands)
	As of March 31, 2014	As of September 30, 2013
Americas....................................................	$181	$169
Europe........................................................	--	1
Total Long-Lived Assets (net).................	$181	$170

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our unaudited consolidated financial statements, and the notes thereto, and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q and the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013. The following discussion and analysis compares our consolidated results of operations for the three and six months ended March 31, 2014 (the “2014 Quarter”and “2014 Period”), with those for the three and six months ended March 31, 2013 (the “2013 Quarter”and “2013 Period” ). All figures in the following discussion are presented on a consolidated basis. All dollar amounts and percentages presented herein have been rounded to approximate values.

Cautionary statement for purposes of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995

The following management’s discussion and analysis includes “forward-looking statements”, as such term is used within the meaning of the Private Securities Litigation Reform Act of 1995. These “forward-looking statements” are not based on historical fact and involve assessments of certain risks, developments, and uncertainties in our business looking to the future. Such forward-looking statements can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “estimate”, “intend”, “continue”, or “believe”, or the negatives or other variations of these terms or comparable terminology. Forward-looking statements may include projections, forecasts, or estimates of future performance and developments. Forward-looking statements contained in this Quarterly Report on Form 10-Q are based upon assumptions and assessments that we believe to be reasonable as of the date of this Quarterly Report on Form 10-Q. Whether those assumptions and assessments will be realized will be determined by future factors, developments, and events, which are difficult to predict and may be beyond our control. Actual results, factors, developments, and events may differ materially from those we assumed and assessed. Risks, uncertainties, contingencies, and developments, including those discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and those identified in “Risk Factors” in Item 1A of Forward’s Annual Report on Form 10-K for the fiscal year ended September 30, 2013, could cause our future operating results to differ materially from those set forth in any forward-looking statement. There can be no assurance that any such forward-looking statement, projection, forecast or estimate contained can be realized or that actual returns, results, or business prospects will not differ materially from those set forth in any forward-looking statement.

Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the results of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments.

BUSINESS OVERVIEW

Trends and Economic Environment

During the past year we have focused on protecting the strong competitive position we have built across several key product categories, especially our Diabetic Products line. We have reinvested a portion of the savings generated by the 2012 restructuring towards expanding and better incentivizing our sales, design and sales support teams, which we believe has improved the level of support we provide to our existing customer base and our ability to market innovative solutions to prospective customers. We remain vigilant in evaluating the effectiveness of the investments we have made in our sales and sales support departments as we seek to maintain a disciplined balance between sales growth and cost control.

We remain challenged by a highly concentrated customer base and product offering, especially with respect to our Diabetic Products line, where we operate in a price sensitive environment in which we continue to experience volatility in demand and downward pricing pressure from our major Diabetic Products customers.

In addition to our investments to grow and diversify our business organically, we are continuing our search process to identify potential acquisition targets that would allow us to further leverage our operating infrastructure and public company fixed costs, as well as diversify our sources of revenue. We anticipate that this search process will be ongoing with the goal of identifying prospective target companies that, if acquired, would be accretive to our organic results.

We continue to be challenged by rising costs from our China-based supplier base, which causes our gross margins to narrow when we are not able to fully pass cost increases through to customers. While our dedicated Asia-based sourcing agent has made meaningful progress in areas such as quality assurance and overall operational performance during the past eighteen months, our concentrated supplier base limits their ability to effectively push back against such rising material costs.

Variability of Revenues and Results of Operations

Because a high percentage of our sales revenues is highly concentrated in a few large customers, and because the volumes of these customers’ order flows to us are highly variable, with short lead times, our quarterly revenues, and consequently our results of operations, are susceptible to significant variability over a relatively short period of time.

Critical Accounting Policies and Estimates

This management’s discussion and analysis of financial condition and results of operations is based upon or derived from the unaudited consolidated financial statements included in this Quarterly Report on Form 10-Q, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and assumptions that are believed to be reasonable under the circumstances. There can be no assurance that actual results will not differ from those estimates and such differences could be significant.

We discuss the material accounting policies that are critical in making these estimates and judgments in our Annual Report on Form 10-K for the fiscal year ended September 30, 2013, under the caption “Management’s Discussion and Analysis—Critical Accounting Policies and Estimates”. There has been no material change in critical accounting policies or estimates since September 30, 2013.

The notes to our audited consolidated financial statements contained in our Annual Report on Form 10-K for the year ended September 30, 2013, and the notes to our unaudited consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q contain additional information related to our accounting policies and should be read in conjunction with the following discussion and analysis relating to our overall financial performance, operations and financial position.

6% Senior Convertible Preferred Stock

Temporary Equity

In accordance with Accounting Standards Codification (“ASC”) 480-10-s99 and Accounting Series Release (“ASR”) 268, equity securities are required to be classified out of permanent equity and classified as temporary equity, as the redemption of the convertible preferred stock is not solely within our control since it is at the option of the holder.

Warrants

In accordance with ASC 815-40, the Company’s warrants were previously classified as a liability, at fair value, as a result of a related registration rights agreement that contains certain requirements for registering the underlying common shares, but has no provision for penalties upon the failure to register. The fair value of the warrants is determined using a Black-Scholes closed-form call option pricing model. At each balance sheet date, this liability’s fair value was re-measured and adjusted with the corresponding change in fair value recorded in the consolidated statement of operations and comprehensive (loss) income. As the Company has met the requirements for registering the underlying common shares, the fair value of the warrants has been reclassified to additional paid-in capital in the accompanying consolidated balance sheet at March 31, 2014.

Preferred Stock Accretion

The carrying amount, at the date of issue is less than the redemption value. As a result of our determination that redemption is probable, the carrying value will be increased by periodic accretions so that the carrying value will equal the redemption amount at the earliest redemption date. Such accretion is recorded as a preferred stock dividend.

Preferred Stock Beneficial Conversion Feature

On the date of issuance, the fair value, or carrying amount, of the securities could be converted into common stock at a discount to the market price of the underlying common stock at the conversion date. Such embedded “beneficial conversion feature”, which is equal to the difference between the accounting conversion price and the fair value of the common stock, is analogous to a dividend and has been recorded as a return to preferred stockholders as of the date of issuance, which is the earliest possible conversion date. As a result of the dividend being recorded upon issuance, there will be no future impact on the Company’s consolidated financial statements.

Results of Operations for the 2014 Quarter compared to the 2013 Quarter

(Loss) Income from Continuing Operations

The 2014 Quarter resulted in a loss from continuing operations of $(0.3) million compared to income from continuing operations of $0.3 million in the 2013 Quarter. This decline of $(0.6) million is primarily due to higher sales and marketing expenses and other expense, and, to a lesser extent, lower gross profit and higher general and administrative expenses as reflected in the table below:

	Main Components of (Loss) Income from Continuing Operations
		(thousands of dollars)
		2014 Quarter	2013 Quarter	Increase (Decrease)
Net sales............................................................................		$6,700	$7,787	$(1,087)

Gross profit.......................................................................		1,404	1,488	(84)
Sales and marketing expenses.......................................		725	511	214
General and administrative expenses...........................		812	771	41
Other expense (income), net..........................................		149	(81)	230
Income tax expense.........................................................		--	--	--
(Loss) income from Continuing Operations..............		$(282)	$287	$(569)

(Loss) income from continuing operations attributable to common shareholders per basic and diluted share was $(0.04) and $0.04 for the 2014 Quarter and 2013 Quarter, respectively.

Net Sales

Net sales in the 2014 Quarter decreased $1.1 million, or 14%, to $6.7 million from $7.8 million in the 2013 Quarter due to lower sales of both Diabetic products and Other products. The tables below set forth sales by channel, product line, and geographic location of our customers for the periods indicated.

Net Sales for 2014 Quarter (millions of dollars)
	APAC	Americas	Europe	Total*
Diabetic products........................	$2.4	$1.4	$2.0	$5.8
Other products.............................	0.3	0.5	0.2	0.9
Total net sales.........................	$2.7	$1.9	$2.2	$6.7

Net Sales for 2013 Quarter (millions of dollars)
	APAC	Americas	Europe	Total*
Diabetic products........................	$1.7	$2.0	$2.7	$6.3
Other products.............................	0.5	0.9	--	1.5
Total net sales.........................	$2.2	$2.9	$2.7	$7.8

* Tables may not total due to rounding.

Diabetic Product Sales

We design to the order of, and sell carrying cases for blood glucose diagnostic kits directly to, OEMs (or their contract manufacturers). The OEM customer or its contract manufacturer packages our carry cases “in box” as a custom accessory for the OEM’s blood glucose testing and monitoring kits, or to a lesser extent, sell them through their retail distribution channels.

Sales of Diabetic products decreased $0.5 million to $5.8 million in the 2014 Quarter, from $6.3 million in the 2013 Quarter. This decrease was primarily due to lower sales to Diabetic Customer C, Diabetic Customer D, and Diabetic Customer B. The decline in sales to Diabetic Customer C was primarily due to lower unit volume experienced in the 2014 Quarter relative to one, large, long-standing program. The decline in sales to Diabetic Customer D was primarily due to lower unit volume experienced in the 2014 Quarter relative to three ongoing programs. The decline in sales to Diabetic Customer B was primarily due to lower unit volume experienced in the 2014 Quarter relative to three ongoing programs, which was offset, in part, by sales contributed by a new program in the 2014 Quarter. These decreases were offset, in part, by higher sales to Diabetic Customer A in primarily respect of three legacy programs and one new program added in the 2014 Quarter.

The following table sets forth our sales by Diabetic Products customer for the periods indicated.

		(millions of dollars)
	2014 Quarter		2013 Quarter	Increase (Decrease)
Diabetic Customer A.........................................................................	$2.3		$1.4	$0.9
Diabetic Customer B.........................................................................	0.8		1.2	(0.4)
Diabetic Customer C.........................................................................	1.6		2.2	(0.6)
Diabetic Customer D.........................................................................	0.8		1.3	(0.5)
All other Diabetic Customers...........................................................	0.3		0.2	0.1
Totals...........................................................................................	$5.8		$6.3	$(0.5)

Sales of carrying cases for blood glucose monitoring kits represented 86% and 81% of our total net sales in the 2014 Quarter and 2013 Quarter, respectively.

Other Product Sales

We design and sell cases and protective solutions to OEMs for a diverse array of portable electronic devices (such as smartphones, tablets, GPS devices, and bar code scanners), as well as a variety of other products (such as firearms, sporting, and other recreational products) on a made-to-order basis that are customized to fit the products sold by our OEM customers.

Sales of Other Products decreased approximately $0.5 million to $0.9 million in the 2014 Quarter from $1.5 million in the 2013 Quarter. This decrease was primarily due to a sales declines with three larger, long-standing, customers: i) a $0.2 million decline in sales to a GPS customer, which had contributed $0.2 million to net sales in the 2014 Quarter; ii) a $0.2 million decline in sales to sports and recreational customer, which contributed $0.2 million to our net sales in the 2014 Quarter; and iii) a $0.2 million decline in sales to a bar code scanner customer, which contributed $0.2 million in net sales in the 2014 Quarter. Decreases in several other customer accounts, of which none were individually material, also served to contribute to the overall decrease in sales of Other products in the 2014 Quarter.

Sales of Other Products represented 14% and 19% of our net sales in the 2014 Quarter and 2013 Quarter, respectively.

Gross Profit

Gross profit decreased $0.1 million, or 6%, to $1.4 million in the 2014 Quarter from $1.5 million in the 2013 Quarter primarily as a result of the lower sales level achieved in the 2014 Quarter. As a percentage of sales, our gross profit was 21% and 19% in the 2014 Quarter and 2013 Quarter, respectively.

Sales and Marketing Expenses

Sales and marketing expenses increased $0.2 million, or 42%, to $0.7 million in the 2014 Quarter compared to $0.5 million in the 2013 Quarter due primarily to higher personnel costs, and, to a lesser extent, higher travel, meals and entertainment costs. Personnel costs increased $0.2 million, or 34%, in the 2014 Quarter primarily as a result of expanding and restructuring our sales and sales support departments. Travel, meals and entertainment costs increased $45 thousand, or 108%, in the 2014 Quarter primarily as a result of increased intercontinental travel for sales support and development. Increases in other components of “Sales and Marketing Expenses” were not material, individually, or in the aggregate.

General and Administrative Expenses

General and administrative expenses increased $41 thousand, or 5% to $0.8 million in the 2014 Quarter from $0.8 million in the 2013 Quarter due primarily to higher professional fees. The increase in professional fees of $0.1 million, or 183%, in the 2014 Quarter was due primarily to higher legal fees, M&A fees, and accounting fees. These increases were offset, in part, by decreases in occupancy costs, personnel costs, and other general and administrative expenses of $39 thousand, $32 thousand, and $15 thousand, respectively. Fluctuations in other components of “General and Administrative Expenses” were not material, individually, or in the aggregate.

Other Expense (income), net

Other expense (income), net, consisting primarily of other expense derived from the change in fair value of our warrants (refer to Note 2 in our Notes to Consolidated Financial Statements) in the case of the 2014 Quarter, and realized and unrealized gains and losses on investments in marketable securities, was $149 thousand of expense in the 2014 Quarter compared to $81 thousand of income in the 2013 Quarter. This fluctuation was due primarily to $188 thousand of other expense resulting from the re-measurement and revaluation of our warrants March 31, 2014, which was offset, in part by an increase in net realized and unrealized gains on investments in marketable securities of $41 thousand.

RESULTS OF OPERATIONS FOR THE 2014 PERIOD COMPARED TO THE 2013 PERIOD

Income from Continuing Operations

Income from continuing operations decreased $0.4 million to $64 thousand in the 2014 Period from $0.5 million in the 2013 Period. The decline is primarily due to a change in Other expense (income), as well as higher sales and marketing expenses in the 2014 Period. These declines were offset, in part, by increased gross profit on a higher sales base and by a decrease in general and administrative expenses in the 2014 Period, as reflected in the table below:

	Main Components of Income from Continuing Operations
		(thousands of dollars)
		2014 Period	2013 Period	Increase (Decrease)
Net sales....................................................................................		$15,115	$14,760	$355

Gross profit................................................................................		3,249	2,958	291
Sales and marketing expenses................................................		1,342	959	383
General and administrative expenses....................................		1,668	1,845	(177)
Other expense (income), net...................................................		174	(314)	484
Income tax expense..................................................................		--	--	--
Income from Continuing Operations...................................		$64	$468	$(399)

(Loss) income from continuing operations attributable to common shareholders per basic and diluted share was $(0.01) and $0.06 for the 2014 Period and 2013 Period, respectively.

Net Sales

Net sales in the 2014 Period increased $0.3 million, or 2%, to $15.1 million from $14.8 million in the 2013 Period primarily due to higher sales of Diabetic products, which was offset, in part, by lower sales of Other products. The tables below set forth sales by channel, product line, and geographic location of our customers for the periods indicated.

Net Sales for 2014 Period (millions of dollars)
	APAC	Americas	Europe	Total*
Diabetic products.............................	$5.0	$3.1	$4.1	$12.2
Other products..................................	1.0	1.2	0.7	2.9
Total net sales.............................	$6.0	$4.4	$4.8	$15.1

Net Sales for 2013 Period (millions of dollars)
	APAC	Americas	Europe	Total*
Diabetic products.............................	$3.3	$3.7	$4.5	$11.5
Other products..................................	1.0	2.0	0.2	3.3
Total net sales.............................	$4.3	$5.8	$4.7	$14.8

* Tables may not total due to rounding.

Diabetic Product Sales

Sales of Diabetic products increased $0.7 million, or 6%, to $12.2 million in the 2014 Period, from $11.5 million in the 2013 Period. This increase was primarily due to higher sales in respect of four legacy programs, and one new program added in the 2014 Period, with Diabetic Customer A. These increases were offset, in part, by lower sales to Diabetic Customer C, Diabetic Customer D, and Diabetic Customer B. The decline in sales to Diabetic Customer C was primarily due to a lower unit volume experienced in the 2014 Period relative to one, large, long-standing program. Lesser fluctuations in other programs with Customer C during the 2014 Period offset each other. The decline in sales to Diabetic Customer D was primarily due to lower unit volume experienced in the 2014 Period relative to three ongoing programs. Lesser fluctuations in other programs with Customer D during the 2014 Period offset each other. The decline in sales to Diabetic Customer B was primarily due to lower unit volume experienced in the 2014 Quarter relative to two ongoing programs, which was offset, in part, by sales contributed by a new program in the 2014 Period.

The following table sets forth our sales by Diabetic Products customer for the periods indicated.

		(millions of dollars)
	2014 Period		2013 Period	Increase (Decrease)
Diabetic Customer A..................................	$4.6		$2.7	$1.9
Diabetic Customer B..................................	2.0		2.2	(0.2)
Diabetic Customer C..................................	3.1		3.7	(0.6)
Diabetic Customer D.................................	2.0		2.5	(0.5)
All other Diabetic Customers...................	0.5		0.4	0.1
Totals...................................................	$12.2		$11.5	$0.7

Sales of carrying cases for blood glucose monitoring kits represented 81% and 78% of our total net sales in the 2014 Period and 2013 Period, respectively.

Other Product Sales

Sales of Other Products decreased approximately $0.4 million, or 11%, to $2.9 million in the 2014 Period from $3.3 million in the 2013 Period. This decrease was primarily due to a $0.3 million decline in sales to a GPS customer, which contributed $0.5 million to net sales in the 2014 Period. In addition, a $0.1 million decline in sales to a bar code scanner customer, which contributed $0.6 million to net sales in the 2014 Period, also contributed to the decrease in Other Products sales. These declines were offset, in part, by the addition of a new camera customer, to which we made first time sales of $0.5 million in the 2014 Period. Fluctuations in other customer accounts, of which none were individually material, served to contribute to the overall decrease in sales of Other products in the 2014 Period.

Sales of Other Products represented 19% and 22% of our net sales in the 2014 Period and 2013 Period, respectively.

Gross Profit

Gross profit increased $0.3 million, or 10%, to $3.2 million in the 2014 Period from $3.0 million in the 2013 Period primarily as a result of the higher sales level achieved in the 2014 Period. As a percentage of sales, our gross profit was 21% and 20% in the 2014 Period and 2013 Period, respectively.

Sales and Marketing Expenses

Sales and marketing expenses increased $0.4 million, or 40%, to $1.3 million in the 2014 Period compared to $1.0 million in the 2013 Period due primarily to higher personnel costs, and to a lesser extent, higher travel and entertainment costs. Personnel costs increased $0.3 million, or 35%, in the 2014 Period primarily as a result of expanding and restructuring our sales and sales support departments. Travel and entertainment expenses increased $0.1 million, or 130%, in the 2014 Period primarily due to increased intercontinental travel for sales support and development. Increases in other components of “Sales and Marketing Expenses” were not material, individually, or in the aggregate.

General and Administrative Expenses

General and administrative expenses decreased $0.2 million, or 10% to $1.7 million in the 2014 Period from $1.8 million in the 2013 Period due primarily to lower personnel costs, occupancy costs, and travel and entertainment costs. Personnel costs decreased $0.1 million, or 15%, primarily due to incentive bonuses and contract employee fees incurred in the 2013 Period as part of our restructuring that were not incurred in the 2014 Period. Also, in connection with our restructuring and relocation of our corporate headquarters from Santa Monica, California to West Palm Beach Florida, we incurred higher travel and entertainment costs, and higher occupancy costs in the 2013 Period, which we were able to reduce in the 2014 Period. Fluctuations in other components of “General and Administrative Expenses” were not material, individually, or in the aggregate.

Other Expense (income), net

Other expense (income), net, consisting primarily of realized and unrealized gains, losses on investments in marketable securities, and other expense derived the change in fair value of our warrants (refer to Note 2 in our Notes to Consolidated Financial Statements) in the case of the 2014 Period, was $0.2 million of expense in the 2014 Period compared to $(0.3) million of income in the 2013 Period. This fluctuation was due primarily to $39 thousand of net realized and unrealized losses on investments in marketable securities in the 2014 Period compared to $0.3 million of net realized and unrealized gains on investments in marketable securities in the 2013 Period. In addition, we incurred $0.2 million of other expense in the 2014 Period that resulted from the re-measurement and revaluation of our warrants as of March 31, 2014.

LIQUIDITY AND CAPITAL RESOURCES

During the 2014 Period, we used $0.3 million of cash in operations, which consisted of net income of $50 thousand, adjusted by $0.3 million for non-cash items (primarily change in the fair value of the warrant liability and share based compensation), and a net use in working capital items of $0.6 million. As to working capital items, cash used in operating activities consisted of increases in accounts receivable and inventories of $0.2 million and $61 thousand, respectively, as well as a decrease in accounts payable of $0.4 million.

These changes were offset, in part, by cash generated from operating activities consisting of a decrease in prepaid and other current assets and increase in accrued expenses and other current liabilities of $11 thousand and $9 thousand, respectively.

The increase in accounts receivable is primarily the result of payment term exensions granted to certain key customers. The decrease in accounts payable is primarily due to lower purchases of inventory in the 2014 Quarter compared to the three-month period ended September 30, 2013.

During the 2013 Period, we used $0.2 million of cash in operations, which consisted of net income of $0.3 million adjusted by $68 thousand for non-cash items and a net use in working capital items of $0.5 million. As to working capital items, cash used in operating activities consisted of decreases in accounts payable and accrued expenses and other current liabilities of $3.1 million and $1.2 million, respectively. These changes were offset, in part, by decreases in accounts receivable, inventories, and prepaid and other current assets of $2.7 million, $1.1 million, and $44 thousand, respectively.

In the 2014 Period, net investing activities used $0.2 million, which consisted of $5.4 million used for purchases of marketable equity securities, $5.2 million generated from sales of marketable equity securities, and $15 thousand used for purchases of property and equipment. In the 2013 Period, net investing activities used $0.4 million of cash, which consisted of $38.5 million used for purchases of marketable equity securities, $38.1 million generated from sales of marketable equity securities, and $30 thousand used for purchases of property and equipment.

In the 2014 Period, net financing activities used $38 thousand to pay dividends on the 6% Senior Convertible Preferred Stock. There were no financing activities in the 2013 Period.

At March 31, 2014, our current ratio (current assets divided by current liabilities) was 3.6; our quick ratio (current assets less inventories divided by current liabilities) was 3.1 ; and our working capital (current assets less current liabilities) was $10.7 million. As of such date, we had no short or long-term debt outstanding.

Our primary source of liquidity is our cash and cash equivalents, and marketable securities on hand. The primary demands on our working capital currently are: i) operating losses, should they occur, and ii) accounts payable arising in the ordinary course of business, the most significant of which arise when we order products from our suppliers. Historically, our sources of liquidity have been adequate to satisfy working capital requirements arising in the ordinary course of business. We anticipate that our liquidity and financial resources for the next twelve months will be adequate to manage our operating and financial requirements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not applicable.

Item 4. Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e)) under the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

In accordance with Exchange Act Rule 13a-15(b), our management, under the supervision and with the participation of our Principal Executive Officer and Principal Financial Officer, performed an evaluation of the effectiveness of the Company’s disclosure controls and procedures as of the end of the fiscal quarter covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Company’s Principal Executive Officer and Principal Financial Officer concluded that the Company’s disclosure controls and procedures were effective, as of the end of the 2014 Quarter, to provide reasonable assurance that information required to be disclosed in the Company’s reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms.

Changes in internal control

Our management, with the participation of our Principal Executive Officer and Principal Financial Officer, performed an evaluation required by Rule 13a-15(d) of the Exchange Act as to whether any change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the 2014 Quarter. In connection with our restatement of the results of operations for the quarter ended June 30, 2013, we identified the following deficiencies in the design and operation of the Company’s disclosure controls and procedures:

Convertible Preferred Stock and Warrants

In connection with our restatement of results of operations for the three-month period ended June 30, 2013, our Principal Executive Officer and our Principal Financial Officer concluded that Forward did not maintain effective controls over the accounting and financial disclosures for its sale of Convertible Preferred Stock and Warrants to accredited investors through a private placement. Specifically, controls were not designed effectively to provide reasonable assurance that the purchase price of the Securities was allocated properly between the Convertible Preferred Stock and Warrants. The material weakness resulted in an error in the accounting and financial disclosure of the embedded beneficial conversion feature of the Convertible Preferred Stock that resulted in a correction of Forward’s consolidated financial statements for the quarter ended June 30, 2013. Additionally, this material weakness could result in misstatements of the aforementioned accounts and disclosures that would result in a material misstatement of the consolidated financial statements that would not be prevented or detected.

During the three month period ended December 31, 2013, we implemented additional controls related to the process for evaluating the impact of complex non-routine financing transactions, such as engaging outside experts to assist in determining the proper valuation and accounting treatment for securities through private placements. In addition, we restated our financial statements for the three and six-month periods ended June 30, 2013 to correct the error related to the material weakness.

Communication of Significant Financial Matters

In addition, in December of 2013, the management of the Company became aware of a failure in the operation of its designed internal controls to ensure that the communication of significant financial matters are made known to senior management, including the Company’s Chief Financial Officer. This failure resulted in the omission of the accrual of a certain item of expense.

During the three month quarter ended December 31, 2013, we implemented a policy to provide for the communication of all material financial events to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions to be made. Such a policy will require all significant contracts to be entered into, and all significant financial decisions to be made, by our Principal Executive Officer or Principal Financial Officer. As a result of such remedial action, management has concluded that, as of December 31, 2013, the above identified material weakness in our internal control over financial reporting has been fully remediated.

We determined that the deficiencies described above constituted “material weaknesses” in our internal control over financial reporting. During the three month period ended December 31, 2013, we completed the remediation of the aforementioned material weaknesses in our internal controls over financial reporting.

Except as described above, our Principal Executive Officer and our Principal Financial Officer concluded that no other changes occurred in the Company’s internal control over financial reporting during the 2014 Quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, the Company may become a party to legal actions or proceedings in the ordinary course of its business. As of March 31, 2014, there were no other such actions or proceedings, either individually or in the aggregate, that, if decided adversely to the Company’s interests, the Company believes would be material to its business.

Item 1A. Risk Factors

Please review our Annual Report on Form 10-K for the fiscal year ended September 30, 2013, for a complete statement of “Risk Factors” that pertain to our business. Please refer to ITEM 2. “Cautionary statement for purposes of the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995 on page [24] of this Quarterly Report on Form 10-Q as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations for further discussion of certain of such risk factors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not Applicable.

Item 3. Defaults Upon Senior Securities

None.

Item 4. mine safety disclosures

Not Applicable.

Item 5. Other Information

Not Applicable.

Item 6. Exhibits

	10.1*	Amendment No. 1 to Amended and Restated Buying Agency and Supply Agreement between Forward Industries, Inc. and Forward Industries (Asia-Pacific) Corporation, dated as of March 11, 2014

	31.1	Certification pursuant to Rule 13a-14(a) under the Exchange Act

	31.2	Certification pursuant to Rule 13a-14(a) under the Exchange Act

	32.1	Certifications of the Chief Executive Officer and Chief Financial Officer under Section 906 of the Sarbanes-Oxley Act of 2002

* Portions have been omitted pursuant to a request for confidential treatment and the omitted portions have been separately filed with the Commission. 34

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: May 15, 2014
	FORWARD INDUSTRIES, INC.
	(Registrant)


	By: /s/ Robert Garrett, Jr.
	Robert Garrett, Jr.
	Chief Executive Officer
	(Principal Executive Officer)


	By: /s/ James O. McKenna III
	James O. McKenna III
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Forward Industries, Inc. - Quarter Report: 2014 March (Form 10-Q)

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

PART II. OTHER INFORMATION